09/01/2026
New research could help doctors better identify patients with hypertrophic cardiomyopathy (HCM) who are at highest risk for sudden cardiac death.
A major study led by UVA Health followed nearly 2,700 people with HCM and found that cardiac MRI and a blood test called NT-proBNP may provide important information about a patient’s risk.
Researchers found that several factors were especially important, including:
The amount of scar tissue in the heart
The overall size and weight of the heart muscle
How well the heart pumps
A history of heart failure
Elevated NT-proBNP levels
HCM affects at least 1 in 500 people, and some people may have no symptoms at all. Better risk assessment could help doctors identify patients who may benefit from potentially lifesaving treatment.
Knowing the risks can save lives. Knowing the warning signs can, too.
Learn more about the study from UVA Health: https://www.uvahealth.com/healthy-balance/new-hypertrophic-cardiomyopathy-study-highest-risk